Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1290

Feb 6, 2021

Temperature, humidity, wind predict second wave of pandemic

Posted by in category: biotech/medical

The ‘second wave’ of the coronavirus pandemic has resulted in much blame placed on a lack of appropriate safety measures. However, due to the impacts of weather, research suggests two outbreaks per year during a pandemic are inevitable.

Feb 6, 2021

Researchers engineer a tiny antibody capable of neutralizing the coronavirus

Posted by in category: biotech/medical

At 2 a.m. one night last April, Michael Schoof triple-checked the numbers on his screen, took a deep breath, and fired off an email he’d been waiting all day to send.

Feb 6, 2021

Insta-crop: CRISPR enables high-speed plant domestication

Posted by in categories: biotech/medical, food

A lanky species of wild rice turns compact and docile in a jiffy.

Feb 6, 2021

New Israeli drug cured 29 of 30 moderate/serious COVID cases in days — hospital

Posted by in category: biotech/medical

Possibly this will make covid-19 less severe and manageable.


Medicine developed at Ichilov moderates immune response, helps prevent deadly cytokine storm, researchers say; 29 of 30 phase 1 trial patients left hospital within 3–5 days.

Feb 6, 2021

The SARS-CoV-2 Virus Mutates Fast: The Science You Need to Understand About Coronavirus Variants and COVID-19 Vaccines

Posted by in categories: biotech/medical, evolution, science

The SARS-CoV-2 virus mutates fast. That’s a concern because these more transmissible variants of SARS-CoV-2 are now present in the U.S., U.K. and South Africa and other countries, and many people are wondering whether the current vaccines will protect the recipients from the virus. Furthermore, many question whether we will we be able to keep ahead of future variants of SARS-CoV-2, which will certainly arise.

In my laboratory I study the molecular structure of RNA viruses – like the one that causes COVID-19 – and how they replicate and multiply in the host. As the virus infects more people and the pandemic spreads, SARS-CoV-2 continues to evolve. This process of evolution is constant and it allows the virus to sample its environment and select changes that make it grow more efficiently. Thus, it is important to monitor viruses for such new mutations that could make them more deadly, more transmissible or both.

Feb 6, 2021

Biomedical engineers from the United States and the University of Sydney have collaborated to develop a surgical glue

Posted by in categories: biotech/medical, materials

This can turn out to be a very important and useful invention for medical science. The elastic and adhesive glue quickly seals wounds after application, without the need of stitches or staples. The glue, called ‘Metro’, quickly seals wounds in just 60 seconds. The gel-like material of the wound glue is activated by Ultraviolet (UV) light and it dissolves shortly after. Metro glue’s elasticity makes it ideal for sealing wounds in body tissues that continually expand and relax like the heart or lungs. The glue has been successfully tested on rodents and pigs. It will soon be used in human trials. Kiran Mazumdar Shaw, who is the chairperson of Biocon — Asia’s leading Biopharmaceuticals enterprise, shared a video about the wound glue. The video by In The Know, shows how the Metro glue works.


Glue for wounds!

/video/1

Feb 6, 2021

Brain stem cells could improve AI

Posted by in categories: biotech/medical, robotics/AI

A new project will see scientists use human brain stem cells on microchips to push the boundaries of artificial intelligence.

Feb 6, 2021

Dr. Rachel Ramoni, Chief R&D Officer, U.S. Dept. of Veterans Affairs (VA) — Facilitating Innovation

Posted by in categories: biotech/medical, health, military

Facilitating Novel Health-Tech and Bio-Medical Innovations For Over 9 Million Veterans — Dr. Rachel Ramoni, Chief of R&D, U.S. Department of Veterans Affairs.


Dr. Rachel Ramoni, is the Chief Research and Development Officer of the United States Department of Veterans Affairs (VA), where she oversees their nationwide research enterprise, encompassing some 2000 active projects, at more than 100 sites, with a total budget of $2 billion in both direct VA support, and research funding from outside entities such as the National Institutes of Health, other federal agencies, and nonprofit and private organizations.

Continue reading “Dr. Rachel Ramoni, Chief R&D Officer, U.S. Dept. of Veterans Affairs (VA) — Facilitating Innovation” »

Feb 6, 2021

Matt Kaeberlein on the biology of aging. Excerpts from an interview with Brian Kennedy

Posted by in categories: biotech/medical, life extension

Excerpts from an enlightening interview / conversation conducted by Brian Kennedy with Matt Kaeberlein on the biology of aging.
The interview took place in November 2020 as the first one under the healthy longevity webinar series organized by Brian Kennedy from the National University of Singapure (NUS).

During the conversation, Matt Kaeberlein makes a nice description about what aging is, as well as about therapies, drugs and other interventions that, at least in animals of various kinds, manage to modulate (delay / reverse) the progress of aging.

Continue reading “Matt Kaeberlein on the biology of aging. Excerpts from an interview with Brian Kennedy” »

Feb 5, 2021

What Happens If We Solve Extinction?

Posted by in categories: biotech/medical, business, existential risks

The human species has driven the planet’s biodiversity into an unprecedented decline, with as many as 1 million species at risk. Traditional conservation methods alone are struggling to offset the speed at which we’re losing species. Biotechnologies that have been developing in the wings are now being brought forward to potentially reverse the damage already done. Meet the scientist behind de-extinction.

#Moonshot #Science #BloombergQuicktake.
——-
Like this video? Subscribe: https://www.youtube.com/Bloomberg?sub_confirmation=1

Continue reading “What Happens If We Solve Extinction?” »